KIAA0930: A Potential Drug Target and Biomarker (G23313)

Target Name: KIAA0930

NCBI ID: G23313

KIAA0930

KIAA0930: A Potential Drug Target and Biomarker

KIAA0930 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of the cell cycle, and its levels have been linked to the development and progression of many diseases, including cancer.

One of the most promising aspects of KIAA0930 is its potential as a drug target. Researchers have identified several potential binding sites on the protein that could be targeted by small molecules. These sites are located in the region of the protein that is responsible for its cell cycle regulation functions, and they are involved in the regulation of key cellular processes that are important for the growth, survival, and reproduction of cells.

In addition to its potential as a drug target, KIAA0930 has also been identified as a potential biomarker for several diseases. For example, KIAA0930 has been shown to be elevated in the blood of individuals with certain types of cancer, and it has been used as a biomarker to predict the outcomes of cancer treatments. Additionally, KIAA0930 has been shown to be involved in the regulation of cellular processes that are important for the development and progression of many other diseases, including neurodegenerative conditions and autoimmune diseases.

Overall, KIAA0930 is a protein that has significant potential as a drug target and biomarker. Its unique structure and its involvement in key cellular processes make it an attractive target for small molecule-based therapies. Further research is needed to fully understand the role of KIAA0930 in disease and to develop effective treatments.

Protein Name: KIAA0930

The "KIAA0930 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIAA0930 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets